Next Article in Journal
A Novel ShK-Like Toxic Peptide from the Transcriptome of the Cnidarian Palythoa caribaeorum Displays Neuroprotection and Cardioprotection in Zebrafish
Next Article in Special Issue
Gut Microbiota and Cardiovascular Uremic Toxicities
Previous Article in Journal
Basics of Antibody Phage Display Technology
Previous Article in Special Issue
Uremic Toxins and Clinical Outcomes: The Impact of Kidney Transplantation
Review

Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD)

1
Nephrology Section, Department of Internal Medicine, Ghent University Hospital, 9000 Ghent, Belgium
2
Department of Nephrology and Hypertension, IIS-Fundacion Jimenez Diaz UAM, 28040 Madrid, Spain
*
Author to whom correspondence should be addressed.
Toxins 2018, 10(6), 237; https://doi.org/10.3390/toxins10060237
Received: 2 May 2018 / Accepted: 11 May 2018 / Published: 12 June 2018
(This article belongs to the Special Issue Uremia and Cardiovascular Disease)
The uremic syndrome, which is the clinical expression of chronic kidney disease (CKD), is a complex amalgam of accelerated aging and organ dysfunctions, whereby cardio-vascular disease plays a capital role. In this narrative review, we offer a summary of the current conservative (medical) treatment options for cardio-vascular and overall morbidity and mortality risk in CKD. Since the progression of CKD is also associated with a higher cardio-vascular risk, we summarize the interventions that may prevent the progression of CKD as well. We pay attention to established therapies, as well as to novel promising options. Approaches that have been considered are not limited to pharmacological approaches but take into account lifestyle measures and diet as well. We took as many randomized controlled hard endpoint outcome trials as possible into account, although observational studies and post hoc analyses were included where appropriate. We also considered health economic aspects. Based on this information, we constructed comprehensive tables summarizing the available therapeutic options and the number and kind of studies (controlled or not, contradictory outcomes or not) with regard to each approach. Our review underscores the scarcity of well-designed large controlled trials in CKD. Nevertheless, based on the controlled and observational data, a therapeutic algorithm can be developed for this complex and multifactorial condition. It is likely that interventions should be aimed at targeting several modifiable factors simultaneously. View Full-Text
Keywords: chronic kidney disease; CKD; mortality; outcomes; uremia; medication; lifestyle; diet; prevention; cardiovascular disease chronic kidney disease; CKD; mortality; outcomes; uremia; medication; lifestyle; diet; prevention; cardiovascular disease
Show Figures

Figure 1

MDPI and ACS Style

Vanholder, R.; Van Laecke, S.; Glorieux, G.; Verbeke, F.; Castillo-Rodriguez, E.; Ortiz, A. Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD). Toxins 2018, 10, 237. https://doi.org/10.3390/toxins10060237

AMA Style

Vanholder R, Van Laecke S, Glorieux G, Verbeke F, Castillo-Rodriguez E, Ortiz A. Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD). Toxins. 2018; 10(6):237. https://doi.org/10.3390/toxins10060237

Chicago/Turabian Style

Vanholder, Raymond, Steven Van Laecke, Griet Glorieux, Francis Verbeke, Esmeralda Castillo-Rodriguez, and Alberto Ortiz. 2018. "Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD)" Toxins 10, no. 6: 237. https://doi.org/10.3390/toxins10060237

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop